MedTrace Logo

Study for Pre-Surgical Weight Loss in Type II Diabetes Patients

NCT00791128 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2017-06-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether the GI Sleeve is safe and effective in treating Type II diabetes patients

Conditions

Interventions

DEVICE

GI Liner

Medical device placed endoscopically in the duodenum, nutritional counseling

Sponsors & Collaborators

  • Morphic Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Eduardo Guimaraes Hourneaux de Moura, MD · Hospital das Clinicas, Sao Paulo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-03-31
Completion
2010-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00791128 on ClinicalTrials.gov